# Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.

> PubMed lists PMID 15228497 in Basic & clinical pharmacology & toxicology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2004-06 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-15228497-teriparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15228497-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15228497-teriparatide-v1.json
- Content SHA-256: `8328de34d5e4a83edea0a787b9b799a227d583a67d05b04a84e7705444b30087`

## Claims and source pins

### Headline

Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. ([`pubmed-observation-pmid-15228497-2013-11-21-b275f2532021`](#source-pubmed-observation-pmid-15228497-2013-11-21-b275f2532021))

### Summary

PubMed lists PMID 15228497 in Basic & clinical pharmacology & toxicology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2004-06 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15228497-2013-11-21-b275f2532021`](#source-pubmed-observation-pmid-15228497-2013-11-21-b275f2532021))

### Paragraph 1

PubMed lists PMID 15228497 in Basic & clinical pharmacology & toxicology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2004-06 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15228497-2013-11-21-b275f2532021`](#source-pubmed-observation-pmid-15228497-2013-11-21-b275f2532021))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15228497-2013-11-21-b275f2532021`](#source-pubmed-observation-pmid-15228497-2013-11-21-b275f2532021))

## Sources

<a id="source-pubmed-observation-pmid-15228497-2013-11-21-b275f2532021"></a>
- **Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. · retained source version 1:2013-11-21:current:b275f25320218cc5a24086db6b1a89e3a2a90793f8acea334fd2d8828f69a99a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15228497/) (`pubmed-observation-pmid-15228497-2013-11-21-b275f2532021`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15228497-teriparatide-v1.json SHA-256: 8328de34d5e4a83edea0a787b9b799a227d583a67d05b04a84e7705444b30087.